On the other hand, glucagon like peptide 1 receptor agonists (GLP-1 RAs) are also effective in terms of glycemic control (both fasting and postprandial) and associated with weight loss and low risk of hypoglycemia. Here, GLP1R is linked to Hypoglycemia.